The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 22,801–22,900 of 31,469
Maache, S., Laaroussi, H., Soulo, N., et al. (2024) · Bioresources and Bioprocessing · doi:10.1186/s40643-024-00769-1 · Cited by 7
Xiang, Q., Xu, H., Liu, Y., & Wu, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-67127-1 · Cited by 7
Berezina, T. A., Berezin, O. O., Hoppe, U. C., Lichtenauer, M., & Berezin, A. Е. (2024) · Biomedicines · doi:10.3390/biomedicines12081857 · Cited by 7
Wang, C., Liu, D., Lu, J., et al. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01726-x · Cited by 7
Plasma YKL-40 during pregnancy and gestational diabetes mellitus
Rinnov, A. R., Rathcke, C. N., Bonde, L., et al. (2015) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2015.06.092 · Cited by 7
Clinical Application of Non-Invasive Markers of Liver Fibrosis
Parsian, H., Alizadeh, M., & Yahyapour, Y. (2013) · InTech eBooks · doi:10.5772/55422 · Cited by 7
Tajiri, Y., Sato, S., Kato, T., Nakayama, H., & Yamada, K. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00076.x · Cited by 7
Korenaga, K., Korenaga, M., Teramoto, F., Suzuki, T., Nishina, S., Sasaki, K., Nakashima, Y., Tomiyama, Y., Yoshioka, N., Hara, Y., et al. (2013) · Hepatology Research · doi:10.1111/hepr.12095 · Cited by 7
Hashimoto, S., Gimeno, S. G. A., Matsumura, L. K., Franco, L. J., Miranda, W. L., & Ferreira, S. R. G. (2007) · PubMed · Cited by 7
Fang, C. Y., Boden, G. H., Siu, P. T., & Tseng, M. (2015) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2015.06.013 · Cited by 7
de Luis, D. A., Bachiller, P., Palacios, T., Conde, R., Izaola, O., de la Fuente, B., & Bouza, J. M. E. (2012) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21528 · Cited by 7
Watanabe, T., Murata, C., & Watanabe, Y. (2005) · PubMed · Cited by 7
de Luis, D. A., Aller, R., Izaola, O., et al. (2012) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21517 · Cited by 7
Demirelli, S., Değirmenci, H., Ermiş, E., İnci, S., Nar, G., Ayhan, M. E., Fırtına, S., Hamur, H., & Durmaz, Ş. A. (2015) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2015.552 · Cited by 7
Digital histology quantification of intra-hepatic fat in patients undergoing liver resection
Parkin, E., O'Reilly, D. A., Plumb, A., Manoharan, P., Rao, M., Coe, P. O., Frystyk, J., Ammori, B. J., Carino, N. D. L., Deshpande, R., et al. (2015) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2015.05.003 · Cited by 7
Gabrielli, L., de Almeida, M. D. C. C., & Aquino, E. M. L. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.04.013 · Cited by 7
Demir, B., Cengiz, H., Ünğan, İ., Gedikbaşı, A., Karakoç, G., Demir, E., & Demir, N. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1018160 · Cited by 7
Ohta, Y., Ishizuka, A., Hayashi, S., et al. (2015) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2015.1026041 · Cited by 7
Benozzi, S. F., Ordoñez, F., Polini, N. N., Alvarez, C., Sellés, J., & Coniglio, R. I. (2009) · PubMed · Cited by 7
Clinical Significance of the Augmentation Index in Patients with Preserved Kidney Function
Hitsumoto, T. (2012) · Journal of Nippon Medical School · doi:10.1272/jnms.79.422 · Cited by 7
The Ratio of Adiponectin to HOMA as an Index of Metabolic Syndrome in Obese Women
de Luis, D. A., Aller, R., Izaola, O., Conde, R., & Sagrado, M. G. (2011) · Annals of Nutrition and Metabolism · doi:10.1159/000331216 · Cited by 7
Bukkapatnam, R. N., Berglund, L., Anuurad, E., Devaraj, S., Hyson, D. A., Rafii, F., Malmstein, C., & Villablanca, A. C. (2009) · Preventive Cardiology · doi:10.1111/j.1751-7141.2009.00043.x · Cited by 8
Apovian, C. M., Bigornia, S., Cullum‐Dugan, D., Schoonmaker, C., Radziejowska, J., Phipps, J. C., Gokce, N., Istfan, N. W., Meyers, A. F., & Lenders, C. M. (2009) · ICAN Infant Child & Adolescent Nutrition · doi:10.1177/1941406408326991 · Cited by 7
Síndrome de Berardinelli-Seip: descrição genética e metabólica de cinco pacientes
Barra, C., Savoldelli, R. D., Manna, T. D., Kim, C. A., Magre, J., Porta, G., Setian, N., & Damiani, D. (2011) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302011000100007 · Cited by 7
Côté, J. A., Nadeau, M., Leboeuf, M., Blackburn, L., & Tchernof, A. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.12.041 · Cited by 7
Utility of Glucagon Stimulation Test in Type 1 Diabetes After Pancreas Transplantation
Hiratsuka, I., Suzuki, A., Kondo-Ando, M., Hirai, H., Maeda, Y., Sekiguchi-Ueda, S., Shibata, M., Takayanagi, T., Makino, M., Fukami, N., et al. (2014) · Transplantation Proceedings · doi:10.1016/j.transproceed.2013.11.027 · Cited by 7
Ahn, K. H., Lee, S. H., Park, H. T., Kim, T., Hur, J. Y., Kim, Y. T., & Kim, S. H. (2010) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2009.01132.x · Cited by 7
Psoriasis and insulin resistance: a review
Fitzgerald, R., Sadlier, M., Connolly, M., & Tobin, A. (2014) · journal of Diabetes Research and Clinical Metabolism · doi:10.7243/2050-0866-3-3 · Cited by 7
Deo, S. S., Mahadik, S. R., Chogle, A. R., Soneji, S. L., & Lulla, C. P. (2007) · Clinical and Experimental Hypertension · doi:10.1080/10641960701615667 · Cited by 7
Interleukin 28B Genotype and Insulin Resistance in Chronic Hepatitis C Patients
Degasperi, E., Valenti, L. V. C., Aghemo, A., et al. (2013) · Antiviral Therapy · doi:10.3851/imp2743 · Cited by 7
Onat, A., Hergenç, G., Ağırbaşlı, M. A., Kaya, Z., Can, G., & Erginel‐Ünaltuna, N. (2009) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2009.018 · Cited by 7
Kuwahara, K., Kochi, T., Nanri, A., Tsuruoka, H., Kurotani, K., Pham, N. M., Akter, S., Kabe, I., & Mizoue, T. (2014) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12323 · Cited by 7
Yamamoto‐Honda, R., Osame, K., Kitazato, H., Shinkai, M., Isogawa, A., Yoshida, Y., Kawazu, S., Akanuma, Y., & Noda, M. (2011) · Diabetology International · doi:10.1007/s13340-011-0024-0 · Cited by 7
Lutz, S. Z., Franck, O., Böhm, A., Machann, J., Schick, F., Machicao, F. E., Fritsche, A., Häring, H., & Staiger, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100391 · Cited by 7
Li, H., Deng, X., Li, Z., Luo, C., Liu, J., & Wang, Y. (2011) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-011-0373-8 · Cited by 7
Laparoscopic bariatric surgery for the treatment of severe hypertriglyceridemia
Hsu, S.-Y., Lee, W., Chong, K., et al. (2014) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2014.05.003 · Cited by 7
Gam, C. M. B. F., Mortensen, O. H., Qvortrup, K., Damm, P., & Quistorff, B. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1599-7 · Cited by 7
Tsuda, S.-I., Nakano, S., Konishi, K., & Koya, D. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.10.011 · Cited by 7
Liu, J., Yuan, X.-J., Liu, J., et al. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.09.021 · Cited by 7
Beat‐to‐beat oscillations in pulse pressure
Virtanen, R., Jula, A., Kuusela, T., & Airaksinen, J. K. E. (2004) · Clinical Physiology and Functional Imaging · doi:10.1111/j.1475-097x.2004.00568.x · Cited by 7
Steele, R. M., Finucane, F. M., Simmons, R. K., Griffin, S. J., Wareham, N. J., & Ekelund, U. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02689.x · Cited by 7
Type 1 and type 2 diabetes mellitus: are they mutually exclusive?
Fatima, A., Khawaja, K., Burney, S., et al. (2013) · Singapore Medical Journal · doi:10.11622/smedj.2013141 · Cited by 7
Watts, G. F., Chan, D. C., & Barrett, P. H. R. (2002) · Metabolism · doi:10.1053/meta.2002.34718 · Cited by 7
Rueda, M. S., Herencia, J. A. C., Orozco, J. M., et al. (2011) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2011.06.006 · Cited by 7
Lemoine, M., Chevaliez, S., Bastard, J., et al. (2015) · Journal of Viral Hepatitis · doi:10.1111/jvh.12408 · Cited by 7
Cardiovascular fitness is impaired in children born small for gestational age
Cafiero, G., Fintini, D., Brufani, C., et al. (2014) · Acta Paediatrica · doi:10.1111/apa.12571 · Cited by 7
The Inverse Relation of CA-125 to Diabetes, Metabolic Syndrome, and Associated Clinical Variables
Esteghamati, A., Seyedahmadinejad, S., Zandieh, A., Esteghamati, A., Gharedaghi, M. H., Sadaghiani, M. S., Saadipoor, A., & Nakhjavani, M. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0058 · Cited by 7
Ibarra-Pastrana, É. N., Plata, M. D. C. C., Álvarez-Hernández, G., & Valencia, M. E. (2012) · International Journal of Endocrinology · doi:10.1155/2012/907818 · Cited by 8
Adiponectin concentration and insulin indicators following overfeeding in identical twins
Ukkola, O. H., Terán-Garcı́a, M., Tremblay, A., Després, J., & Bouchard, C. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03345579 · Cited by 7
Insulin Sensitivity from Preschool to School Age in Patients with Severe Obesity
Manco, M., Spreghini, M. R., Luciano, R., Pensini, C., Sforza, R. W., Rustico, C., Cappa, M., & Morino, G. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068628 · Cited by 7
Yang, Z., Yang, X., Xu, J., Sun, Y., Shi, Y., & Fang, S. (2013) · Gynecologic and Obstetric Investigation · doi:10.1159/000356960 · Cited by 7
Prostate Specific Antigen Mass Ratio Potential as a Prostate Cancer Screening Tool
Choi, H.-C., Park, J., Cho, B., Son, K. Y., & Kwon, H.-T. (2010) · The Journal of Urology · doi:10.1016/j.juro.2010.03.138 · Cited by 7
Yu, Y., Venners, S. A., Wang, B., Brickman, W. J., Zimmerman, D., Li, Z., Wang, L., Liu, X., Tang, G., Xing, H., et al. (2010) · Metabolism · doi:10.1016/j.metabol.2009.10.029 · Cited by 7
Roes, S. D., Dehnavi, R. A., Westenberg, J. J. M., et al. (2011) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-13-65 · Cited by 7
Nguyen, Q. M., Srinivasan, S. R., Xu, J.-H., Chen, W., & Berenson, G. S. (2009) · Annals of Epidemiology · doi:10.1016/j.annepidem.2009.10.001 · Cited by 7
Impaired endogenous fibrinolytic capacity in prehypertensive men
Diehl, K. J., Weil, B. R., Greiner, J. J., Wright, K. P., Stauffer, B. L., & DeSouza, C. A. (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2014.120 · Cited by 7
Kahveci, Ç., Gündüz, M. K., Çağatay, P., et al. (2012) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2012.05.002 · Cited by 7
Metabolic Predictors of Inflammation, Adhesion, and Coagulability in Healthy Younger‐aged Adults
Mills, P. J., Shapiro, D., Goldstein, I. B., Ottaviani, C., Pung, M. A., Khandrika, S., von Känel, R., & Rutledge, T. R. (2008) · Obesity · doi:10.1038/oby.2008.420 · Cited by 7
Yu, Q., Takahashi, T., Nomura, M., & Kobayashi, S. (2013) · Chinese Medicine · doi:10.4236/cm.2013.44019 · Cited by 7
Non-alcoholic fatty liver disease per se is not associated with carotid atherosclerosis
Genç, H., Doğru, T., Çelebi, G., Tapan, S., Ercin, M., Örs, F., Açıkel, C., Demirci, Y., Gürel, H., & Bağcı, S. (2013) · Gulhane Medical Journal · doi:10.5455/gulhane.39850 · Cited by 8
Erşanlı, D., Top, C., Öncül, O., Aydin, A., & Terekeci, H. (2007) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510601110148 · Cited by 7
Prévost, G., Ducrotte, P. R., Cailleux, A.-F., Khalfi, K., Basuyau, J. P., Lefèbvre, H., & Kuhn, J. M. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12150 · Cited by 7
Vitamin D Intake and Cardiometabolic Risk Factors in Adolescents
Moreira, C. M. M., Moreira, P. A. M., Abreu, S., et al. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0065 · Cited by 7
St. John’s Wort Has Metabolically Favorable Effects on Adipocytes In Vivo
Fuller, S. E., Richard, A. J., Ribnicky, D., Beyl, R. A., Mynatt, R. L., & Stephens, J. M. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/862575 · Cited by 7
Visfatina en pacientes obesos, relación con factores de riesgo cardiovascular, un estudio tranversal
de Luis, D. A., Ballesteros-Pomar, M. D., Ruiz, E., Muñoz, C., Penacho, Á., Iglesias, P., Guzman, A. L., Abreu, C., Maldonado, A., Delgado‐Rodríguez, M., et al. (2011) · Medicina Clínica · doi:10.1016/j.medcli.2010.09.033 · Cited by 7
Silva, L. G. D. O. E., Manso, J. E. F., da Silva, R. A. R. N., Pereira, S., Saboya, C. J., & Rangel, C. W. (2012) · ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) · doi:10.1590/s0102-67202012000400008 · Cited by 7
Wong, J., Molyneaux, L. M., Zhao, D., Constantino, M., Gray, R. S., Twigg, S. M., Xu, Z. R., & Yue, D. K. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2007.04.003 · Cited by 7
Genetic variants of the HSD11B1 gene promoter may be protective against polycystic ovary syndrome
Grolmusz, V. K., Ács, O. D., Feldman, K., Szappanos, Á., Stenczer, B., Fekete, T., Szendei, G., Reismann, P., Rácz, K., & Patócs, A. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3473-2 · Cited by 7
Apelin rs2235306 polymorphism is not related to metabolic syndrome in Egyptian women
Mehanna, E. T., Abo–Elmatty, D. M., Ghattas, M. H., et al. (2014) · Egyptian Journal of Medical Human Genetics · doi:10.1016/j.ejmhg.2014.11.004 · Cited by 7
The relationship between γ-glutamyltransferase and adiponectin in nonalcoholic women
Kim, J. A., Kim, S. M., & Yoon, D. (2007) · Metabolism · doi:10.1016/j.metabol.2006.12.010 · Cited by 7
Toonen, E. J. M., Laskewitz, A. J., van Dijk, T. H., Bleeker, A., Grefhorst, A., Schouten, A. E., Bastiaanssen, E. A. J., Ballak, D. B., Koenders, M. I., van Doorn, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098684 · Cited by 7
Duodenal-Jejunal Bypass Restores Insulin Action and Βeta-Cell Function in Hypothalamic-Obese Rats
Bonfleur, M. L., Ribeiro, R. A., Pavanello, A., Soster, R., Lubaczeuski, C., Araújo, A. C. F., Boschero, A. C., & Balbo, S. L. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1427-3 · Cited by 7
Gómez-Marcos, M. Á., Patino-Alonso, M. C., Recio-Rodriguez, J. I., et al. (2012) · European Journal of Nutrition · doi:10.1007/s00394-012-0451-0 · Cited by 7
Rajagopal, G., Reddy, A., Harinarayan, C. V., Suresh, V., Bitla, A. R. R., Rao, S. P. V. L. N., & Sachan, A. (2012) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0127 · Cited by 8
Zhang, J., Zhou, L., Tang, L., & Xu, L. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1556 · Cited by 7
Matthews, D. R., & Lévy, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60865-5 · Cited by 7
Self-citationBarseem, N. F. (2015) · Journal of Obesity & Weight loss Therapy · doi:10.4172/2165-7904.1000250 · Cited by 7
Çelik, E., Çelik, Ö., Yilmaz, E., et al. (2012) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2012.10.032 · Cited by 7
Mijares, A. H., Fortuny, C. R., Triguero, M. L. M., et al. (2004) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(06)60655-5 · Cited by 7
Shinohara, T., Takahashi, N., Abe, I., Okada, N., Wakisaka, O., Yufu, K., Hara, M., Nakagawa, M., Saikawa, T., & Yoshimatsu, H. (2011) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2011.03.011 · Cited by 7
Karásek, D., Vaverková, H., Halenka, M., Jackuliaková, D., Fryšák, Z., & Novotný, D. (2011) · Biomedical Papers · doi:10.5507/bp.155.2011.002 · Cited by 7
Rosiglitazone Causes Endothelial Dysfunction in Humans
Perampaladas, K., Gori, T., & Parker, J. D. (2011) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248411425490 · Cited by 7
The Effects of Reduction Mammaplasty on Serum Leptin Levels and Insulin Resistance
Uzun, H., Bitik, O., Baltu, Y., Sönmez, Ç., & Kaymak, A. Ö. (2015) · International Journal of Endocrinology · doi:10.1155/2015/719824 · Cited by 7
Choi, Y.-M., Lee, J., & Han, J.-S. (2009) · Korean Diabetes Journal · doi:10.4093/kdj.2009.33.4.324 · Cited by 7
Diabetes mellitus en inmigrantes indostanos jóvenes. Un estudio descriptivo
Franch‐Nadal, J., Peinado, R. M., Calafell, N. R., et al. (2008) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(08)75842-x · Cited by 7
Aller, R., de Luis, D. A., Fernández-Salazar, L. I., Calle, F., Velayos, B., Izaola, O., Sagrado, M. G., Conde, R., & González, J. M. D. (2009) · PubMed · Cited by 7
Shin, M., Shim, E., Kang, B., Park, S., Lee, S., Shim, C. Y., Park, E., & Chung, N. (2009) · Yonsei Medical Journal · doi:10.3349/ymj.2009.50.6.757 · Cited by 7
Deng, H., Deng, H.-Z., Hong, D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100459 · Cited by 7
A behavioral intervention in a cohort of Japanese-Brazilians at high cardiometabolic risk
de Almeida-Pititto, B., Griffin, S. J., Sharp, S. J., Hirai, A. T., Gimeno, S. G. A., & Ferreira, S. R. G. (2012) · Revista de Saúde Pública · doi:10.1590/s0034-89102012005000045 · Cited by 7
Ramesh, J. (2012) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000222 · Cited by 7
de Luis, D. A., Sagrado, M. G., Aller, R., et al. (2011) · PubMed · Cited by 7
Torrens, J. M., Orellana‐Gavaldà, J. M., Palou, M., Sánchez, J., Herrero, L., Picó, C., Serra, D., & Palou, A. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358714 · Cited by 7
Roeske‐Nielsen, A., Buschard, K., Manson, J. E., et al. (2009) · Experimental Diabetes Research · doi:10.1155/2009/429593 · Cited by 7
Burghardt, K. J., Pop‐Busui, R., Bly, M. J., Grove, T. B., Taylor, S. F., & Ellingrod, V. L. (2012) · Clinical and Translational Science · doi:10.1111/cts.12001 · Cited by 7
Lee, I. S., Lee, J. H., Kim, H. J., Lee, J. M., Lee, S., Kim, H. S., Lee, J. M., Park, K. S., & Ku, B. J. (2013) · Europe PMC (PubMed Central) · doi:10.3233/dma-120949 · Cited by 7
Karakan, Ş., Sezer, S., Özdemir, F. N., et al. (2012) · Renal Failure · doi:10.3109/0886022x.2012.676493 · Cited by 7
Johns, B., Abbasi, F., & Reaven, G. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.152744 · Cited by 7
(2015) · International Journal of Pharmacy and Pharmaceutical Sciences · Cited by 7
Jürs, A., Pedersen, L. R., Olsen, R. H., et al. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0151-9 · Cited by 7
Žákovičová, E., Charvat, J., Mokrá, D., Šváb, P., & Kvapil, M. (2014) · PubMed · Cited by 7
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
